Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
The Cochrane Database of Systematic Reviews
|
October 30, 2003
New generation antipsychotics for first episode schizophrenia
C Rummel, J Hamann, W Kissling, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 20, 2001
Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy
W Steimer, B Müller, S Leucht, et al.
The Pharmacogenomics Journal
|
May 20, 2009
Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?
B Laika, S Leucht, S Heres, et al.
Fortschritte Der Neurologie-Psychiatrie
|
May 25, 2013
Pharmacological treatment of schizophrenia
S Leucht, S Heres, W Kissling, et al.
Schizophrenia Research
|
February 16, 1999
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
S Leucht, G Pitschel-Walz, D Abraham, et al.
Acta Psychiatrica Scandinavica
|
December 5, 2013
Do patients with paranoid and disorganized schizophrenia respond differently to antipsychotic drugs?
C Corves, R R Engel, J Davis, et al.
The Pharmacogenomics Journal
|
July 29, 2009
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
B Laika, S Leucht, S Heres, et al.
Acta Psychiatrica Scandinavica
|
October 9, 2007
Physical illness and schizophrenia: a review of the literature
S Leucht, T Burkard, J Henderson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
November 12, 2010
Drowning in numbers-what psychiatrists mean when talking to patients about probabilities of risks and benefits of medication
J Hamann, R Mendel, M Bühner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 16, 2004
Language bias in neuroscience--is the Tower of Babel located in Germany?
S Heres, S Wagenpfeil, J Hamann, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
The Cochrane Database of Systematic Reviews
|
October 30, 2003
New generation antipsychotics for first episode schizophrenia
C Rummel, J Hamann, W Kissling, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 20, 2001
Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy
W Steimer, B Müller, S Leucht, et al.
The Pharmacogenomics Journal
|
May 20, 2009
Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?
B Laika, S Leucht, S Heres, et al.
Fortschritte Der Neurologie-Psychiatrie
|
May 25, 2013
Pharmacological treatment of schizophrenia
S Leucht, S Heres, W Kissling, et al.
Schizophrenia Research
|
February 16, 1999
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
S Leucht, G Pitschel-Walz, D Abraham, et al.
Acta Psychiatrica Scandinavica
|
December 5, 2013
Do patients with paranoid and disorganized schizophrenia respond differently to antipsychotic drugs?
C Corves, R R Engel, J Davis, et al.
The Pharmacogenomics Journal
|
July 29, 2009
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
B Laika, S Leucht, S Heres, et al.
Acta Psychiatrica Scandinavica
|
October 9, 2007
Physical illness and schizophrenia: a review of the literature
S Leucht, T Burkard, J Henderson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
November 12, 2010
Drowning in numbers-what psychiatrists mean when talking to patients about probabilities of risks and benefits of medication
J Hamann, R Mendel, M Bühner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 16, 2004
Language bias in neuroscience--is the Tower of Babel located in Germany?
S Heres, S Wagenpfeil, J Hamann, et al.
Page
of 8